Citius Pharmaceuticals Announces $15 Million Registered Direct Offering

6h ago, source:

Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to ...

CTXR Citius Pharmaceuticals, Inc.

4d ago, source: Seeking Alpha

Citius Pharmaceuticals, Inc., a late-stage pharmaceutical company, engages in the development and commercialization of critical care products focusing on oncology products, anti-infectives ...

Positive Outlook for Citius Pharmaceuticals with Lymphir’s FDA Resubmission and Market Potential

1mon ago, source: Business Insider

Michael Okunewitch, an analyst from Maxim Group, maintained the Buy rating on Citius Pharmaceuticals (CTXR – Research Report). The associated price target is $4.00. Michael Okunewitch’s rating ...

Citius Pharmaceuticals to Present at the LD Micro Invitational XIV Investor Conference

22d ago, source: Yahoo Finance

CRANFORD, N.J., April 4, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late ...

Citius Pharmaceuticals, Inc. Secures $2.4 million through New Jersey Economic Development Program

1mon ago, source: Yahoo Finance

CRANFORD, N.J., March 7, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or the "Company") (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development and ...

Citius Pharmaceuticals Inc

1mon ago, source: CNN

Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct ...

Citius Pharmaceuticals Inc CTXR

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Citius Pharmaceuticals, Inc. (CTXR)

1y ago, source: Yahoo Finance

Overall score is calculated based on proprietary scores based on sector averages in key company indicators: fair value, dividends, innovation, hiring, and insider sentiment. Note: if you don't see ...

Citius Pharmaceuticals Inc.

3y ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Citius Pharmaceuticals Inc (CTXR)

15d ago, source: Investing

CRANFORD, N.J. - Citius Pharmaceuticals, Inc. (NASDAQ: NASDAQ:CTXR), a biopharmaceutical company focusing on critical care products, has filed a new Form S-3 shelf registration ...